References
- SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine20106566267120230912
- SinghPPrasuhnDYehRMBio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivoJ Control Release20071201–2415017512998
- XieGSunJZhongGShiLZhangDBiodistribution and toxicity of intravenously administered silica nanoparticles in miceArch Toxicol201084318319019936708
- YoonHYSaravanakumarGHeoRHydrotropic magnetic micelles for combined magnetic resonance imaging and cancer therapyJ Control Release2012160369269822543013
- Briley-SaeboKHustvedtSOHaldorsenABjornerudALong-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agentJ Magn Reson Imaging200420462263115390223
- InohKMuramatsuHToriiSDoxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drugJpn J Clin Oncol200636420721116611663
- MahmoudiMSantSWangBLaurentSSenTSuperparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapyAdv Drug Deliv Rev2011631–2244620685224
- Kim doKChangJHKangYJEfficient internalization of peptide-conjugated SPIONs in dendritic cells for tumor targetingJ Nanosci Nanotechnol20121275191519822966544
- VingerhoedsMHHaismaHJvan MuijenMvan de RijtRBCrommelinDJStormGA new application for liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugsFEBS Lett199333634854908282116
- MunnierECohen-JonathanSLinassierCNovel method of doxorubicin-SPION reversible association for magnetic drug targetingInt J Pharm20083631–217017618687392
- LarouiHSitaramanSVMerlinDGastrointestinal delivery of anti-inflammatory nanoparticlesMethods Enzymol201250910112522568903
- WangJWangXSongYZhuCWangKGuoZDetecting and delivering platinum anticancer drugs using fluorescent maghemite nanoparticlesChem Commun (Camb)201349272786278823439956
- CarneyCETranADWangJSchabelMCSherryADWoodsMTowards the rational design of MRI contrast agents: delta-substitution of lanthanide(III) NB-DOTA-tetraamide chelates influences but does not control coordination geometryChemistry20111737103721037821837722
- MartinezGVZhangXGarcia-MartinMLImaging the extracellular pH of tumors by MRI after injection of a single cocktail of T1 and T2 contrast agentsNMR Biomed201124101380139121604311
- WuYCarneyCEDentonMPolymeric PARACEST MRI contrast agents as potential reporters for gene therapyOrg Biomol Chem20108235333533820848030
- WuYZhouYOuariOPolymeric PARACEST agents for enhancing MRI contrast sensitivityJ Am Chem Soc200813042138541385518817395
- BorelABeanJFClarksonRBTowards the rational design of MRI contrast agents: electron spin relaxation is largely unaffected by the coordination geometry of gadolinium(III)-DOTA-type complexesChemistry20081492658266718283704
- WoodsMBottaMAvedanoSWangJSherryADTowards the rational design of MRI contrast agents: a practical approach to the synthesis of gadolinium complexes that exhibit optimal water exchangeDalton Trans2005243829383716311635
- LinSPBrownJJMR contrast agents: physical and pharmacologic basicsJ Magn Reson Imaging200725588489917457803
- FrullanoLCatanaCBennerTSherryADCaravanPBimodal MR-PET agent for quantitative pH imagingAngew Chem Int Ed Engl201049132382238420191650
- ZhangBLiQYinPUltrasound-triggered BSA/SPION hybrid nanoclusters for liver-specific magnetic resonance imagingACS Appl Mater Interfaces20124126479648623151093
- YooMKParkIKLimHTFolate-PEG-superparamagnetic iron oxide nanoparticles for lung cancer imagingActa Biomater2012883005301322543005
- BarrefeltAABrismarTBEgriGMultimodality imaging using SPECT/CT and MRI and ligand functionalized 99mTc-labeled magnetic microbubblesEJNMMI Res2013311223442550
- WellsDJAnimal welfare and the 3Rs in European biomedical researchAnn N Y Acad Sci20111245141622211967
- MaddenJCHewittMPrzybylakKVandebrielRJPiersmaAHCroninMTStrategies for the optimisation of in vivo experiments in accordance with the 3Rs philosophyRegul Toxicol Pharmacol201263114015422446816
- SchiffelersMJBlaauboerBJHendriksenCFBakkerWERegulatory acceptance and use of 3R models: a multilevel perspectiveALTEX201229328730022847256
- PeyratoutCSDahneLTailor-made polyelectrolyte microcapsules: from multilayers to smart containersAngew Chem Int Ed Engl200443293762378315258935
- MorawietzGRuehl-FehlertCKittelBRevised guides for organ sampling and trimming in rats and mice. Part 3. A joint publication of the RITA and NACAD groupsExp Toxicol Pathol200455643344915384249
- Briley-SaeboKCJohanssonLOHustvedtSOClearance of iron oxide particles in rat liver: effect of hydrated particle size and coating material on liver metabolismInvest Radiol200641756057116772849
- ShiRZhuACChenDFIn vitro degradation of starch/PVA films and biocompatibility evaluationJ Appl Polym Sci20101151346357
- SawantRMSawantRRGultepeENanosized cancer cell-targeted polymeric immunomicelles loaded with superparamagnetic iron oxide nanoparticlesJ Nanopart Res200917771785
- AlbukhatySNaderi-ManeshHTiraihiTIn vitro labeling of neural stem cells with poly-L-lysine coated super paramagnetic nanoparticles for green fluorescent protein transfectionIran Biomed J2013172717623567848
- ZhuAYuanLJinWPolysaccharide surface modified Fe3O4 nanoparticles for camptothecin loading and releaseActa Biomater2009551489149819286431
- MondalekFGZhangYYKroppBThe permeability of SPION over an artificial three-layer membrane is enhanced by external magnetic fieldJ Nanobiotechnology20064416603066
- KimDKMikhaylovaMWangFHStarch-coated superparamagnetic nanoparticles as MR contrast agentsChem Mater2003152343434351
- RappeportEDLoftALiver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomographyAbdom Imaging200732562463417710359
- RappeportEDLoftABerthelsenAKContrast-enhanced FDG-PET/CT vs SPIO-enhanced MRI vs FDG-PET vs CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmationActa Radiol200748436937817453514
- FlorisAArduAMusinuASPION@liposomes hybrid nanoarchitectures with high density SPION associationSoft Matter201171362396247
- GrishenkovDPecorariCBrismarTBParadossiGCharacterization of acoustic properties of PVA-shelled ultrasound contrast agents: ultrasound-induced fracture (part II)Ultrasound Med Biol20093571139114719427102
- BrismarTBGrishenkovDGustafssonBMagnetite nanoparticles can be coupled to microbubbles to support multimodal imagingBiomacromolecules20121351390139922458325
- ZahrASDavisCAPishkoMVMacrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol)Langmuir200622198178818516952259
- BeduneauAMaZGrotepasCBFacilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticlesPloS One200942e434319183814
- NicoleteRdos SantosDFFaccioliLHThe uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory responseInt Immunopharmacol201111101557156321621649
- BaconBRStarkDDParkCHFerrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administrationJ Lab Clin Med198711021641713598345